O'Donoghue ML, Giugliano RP, Sabatine MS. Response by O'Donoghue et al to Letter Regarding Article, "Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease". Circulation 2023;147:1258-1259.
PMID: 37068132